In the current trading session, Enliven Therapeutics Inc’s (ELVN) stock is trading at the price of $21.71, a gain of 10.43% over last night’s close. So, the stock is trading at a price that is -27.71% less than its 52-week high of $30.03 and 63.23% better than its 52-week low of $13.30.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ELVN’s SMA-200 is $22.29.
ELVN’s price to book ratio for the most recent quarter was 3.69, resulting in an 3.68 price to cash per share for the period.
How does Enliven Therapeutics Inc (ELVN) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Enliven Therapeutics Inc (NASDAQ: ELVN) Ownership Details
I will give a breakdown of the key shareholders in Enliven Therapeutics Inc (ELVN). Recent figures show that the company’s insiders hold 5.56% of shares. A total of 180 institutional investors hold shares in the company, making 103.43% of its stock and 109.52% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Orbimed Advisors LLC. holding total of 7.96 shares that make 16.22% of the company’s total number of shares and are currently priced at 176.06 million.
The securities firm FMR, LLC holds 6.61 shares of ELVN, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 13.47% , and the holding percentage of shares is valued at 146.2 million.
An overview of Enliven Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Enliven Therapeutics Inc (ELVN) traded 407,879 shares per day, with a moving average of $18.79 and price change of +2.52. With the moving average of $18.41 and a price change of +0.48, about 374,446 shares changed hands on average over the past 50 days. Finally, ELVN’s 100-day average volume is 307,125 shares, alongside a moving average of $19.78 and a price change of -1.66.
